| Document |
Document Title |
|
WO/2016/097389A1 |
The invention relates to benzenesulfonamide derivatives of formula (I), the pharmaceutically acceptable addition salts thereof, the hydrates and/or solvates thereof, and the use of same as inverse agonists of retinoid-related orphan rece...
|
|
WO/2016/093399A1 |
The present invention is directed to a lithium sulfonyl imide salt containing fluorine and its purification method and, more particularly to, a lithium sulfonyl imide salt containing fluorine and its purification method that includes rec...
|
|
WO/2016/091772A1 |
The invention relates to a method for producing an oxysulphidic and fluorinated derivative in the form of a salt of formula (II) Ea-SOO-Q+ (II) comprising providing an ionic liquid compound of formula (I) in the liquid state Ea-SOO-Q+ (I...
|
|
WO/2016/094897A1 |
Described herein are methods and compositions relating to the treatment of e.g., cancer, autoimmune disease, immune deficiency, and/or neurodegenerative disease. In some embodiments, the methods of treatment relate to administering a com...
|
|
WO/2016/088082A1 |
The present invention provides a compound of formula (I): (I) a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents an...
|
|
WO/2016/086762A1 |
The present invention belongs to the field of chemical synthesis, and in particular relates to a benzylsulfamide substituted acrylamide derivative. The advantages of the present invention lie in: (1) a traditional preparation route is ad...
|
|
WO/2016/085391A1 |
The present invention relates to bis(sulfonamide) compounds and pharmaceutically acceptable salts thereof. The present invention also relates to pharmaceutical compositions comprising these compounds and to their use as a medicament for ...
|
|
WO/2016/084792A1 |
[Problem] To provide: an ionic liquid having a low melting point, the ionic liquid being obtained using a highly ion-conductive polymer; a method for producing the same; and various uses of this ionic liquid. [Solution] A method for prod...
|
|
WO/2016/085392A1 |
The present invention relates to bis(sulfonamide) compounds and pharmaceutically acceptable salts thereof. The present invention also relates to pharmaceutical compositions comprising these compounds and to their use as a medicament for ...
|
|
WO/2016/080384A1 |
[Problem] To provide a (fluorosulfonyl)perfluoroalkanesulfonylimide salt with high selectivity with high yield. [Solution] A (fluorosulfonyl)perfluoroalkanesulfonylimide salt is produced by: obtaining a solution containing a perfluoroalk...
|
|
WO/2016/075330A1 |
The present invention relates to a novel class of compounds having the structure of formula (I) and pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof. These compounds inhibit o...
|
|
WO/2016/072452A1 |
[Problem] To provide a novel therapeutic medicine capable of suppressing the activity of a lipid-metabolizing enzyme deacylase that can cause the decrease in the amount of sphingolipid ceramide in the surface layer of skin, which is one ...
|
|
WO/2016/069955A1 |
Protease inhibitors, particularly aspartyl protease inhibitors, and more particularly HIV protease inhibitors which are boronated to enhance activity or to enhance entry into cells. Compounds, prodrugs and salts thereof of this invention...
|
|
WO/2016/067311A1 |
(Z)-3,4,5-Trimethoxystyrylbenzenesulfonamides as potential anticancer agents [Formula should be inserted here] The present invention relates to a compound of general formula A.The invention provides the synthesis of (Z)-3,4,5-trimethoxys...
|
|
WO/2016/062585A1 |
The present invention relates to a compound of formula (I) wherein: wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and G are as defined herein; and wherein the compound of formula (I) is optionally present as an agrochemically acce...
|
|
WO/2016/059093A1 |
The present invention relates to sulfonylurea analogous compounds comprising a sulfonylurea moiety and a photoresponsive moiety. The present invention further relates to methods for generating the sulfonylurea analogous compounds of the ...
|
|
WO/2016/042298A1 |
The invention provides methods for the preparation of ligands for complexes, methods for preparing complexes and complexes having those ligands. Also provided is the use of a complex as a catalyst in a method of synthesis.
|
|
WO/2016/034971A1 |
The invention relates to sulfonamide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes. More particularly the invention relates to a sul...
|
|
WO/2016/034327A1 |
Novel 2,2'-diamino biaryls of formula (I), (II) and (III), wherein R1-R10, R1'-R10', X1 - X3 and X1-X3' are defined in claim 1. The invention also relates to an electrochemical method for the production thereof.
|
|
WO/2016/034330A1 |
Novel 2,2'-diamino biaryls of formula (I), (II) and (III), wherein R1-R10, R1'-R10' and X1-X3 are defined in claim 1. The invention also relates to an electrochemical method for the production thereof.
|
|
WO/2016/034328A1 |
The invention relates to novel 2,2'-diamino biaryls of formula (I), (IIa), (IIb) and (III), wherein R1-R10, R1'-R10' and X1-X3 are defined in claim 1. The invention also relates to an electrochemical method for the production thereof.
|
|
WO/2016/033341A1 |
The present invention relates to a new compound of formula (I) wherein the variables have the meaning as indicated in the claims; or an enantiomer or salt thereof. The compounds of formula (I) are useful in the control of parasites, in p...
|
|
WO/2016/029136A1 |
Disclosed are novel benzamide compounds and the uses thereof for treating diseases and disorders in a patient in need thereof by increasing cellular levels of A3G and/or other members of the A3 family of proteins in the patient. The disc...
|
|
WO/2016/019630A1 |
Disclosed is a method for synthesizing 1,3-disubstituted allene with high optical activity, namely a method for preparing 1,3-disubstituted allene with high optical activity in one step of functionalizing terminal alkyne, aldehyde and ch...
|
|
WO/2016/017754A1 |
This filter medium for separating a liquid containing water and oil and having a channel for the liquid also has a substrate constituting the channel, and one or more types of nitrogen-containing fluorine-based compounds present on the s...
|
|
WO/2016/017686A1 |
This hydrophilic oil repellent agent includes at least one species of nitrogen-containing fluorine compound. The nitrogen-containing fluorine compound includes, in the molecule thereof, any one hydrophilicity-imparting group selected fro...
|
|
WO/2016/008862A1 |
The invention relates to substituted vinyl and alkynyl cyanocycloalkanols and vinyl and alkynyl cyanoheterocyclylalkanols of general formula (I) or the salts thereof, wherein [X-Y], Q, R1, R2, A1, A2, V, W, m and n have the definitions s...
|
|
WO/2016/009448A1 |
The present invention provides a process for the preparation of dibenzenesulfonimide.
|
|
WO/2015/197309A1 |
The present invention is related to a novel and improved process for the manufacture of compounds of formula (I) or salts thereof herein designated as benzylsulfonyl-Ser-X-4-amidinobenzylamide, wherein R is a C1 to C6 linear or branched ...
|
|
WO/2015/193255A1 |
The present invention is directed to novel compounds of Formula (I), pharmaceutically acceptable salts or solvates thereof, and their use.
|
|
WO/2015/195423A1 |
The present invention relates to a new compound of formula (I) wherein the variables have the meaning as indicated in the claims; or an enantiomer or salt thereof. The compounds of formula (I) are useful in the control of parasites, in p...
|
|
WO/2015/194293A1 |
This lubricant contains a protic ionic liquid having a conjugate acid (B+) and a conjugate base (X-), the ionic liquid is represented by general formula (1), and the conjugate base is one of the conjugate base of sulfonic acid, the conju...
|
|
WO/2015/190118A1 |
The present invention relates to an onium salt, an acrylic acid copolymer containing the onium salt, and an antistatic agent containing the onium salt or the acrylic acid copolymer. The present invention provides an onium salt capable ...
|
|
WO/2015/191799A1 |
Disclosed are compounds of Formula (IVA), or a salt thereof, and pharmaceutical formulations (pharmaceutical compositions) comprising those compounds, or a salt thereof: Formula (IVA), wherein "RIa", "RIb", "RIc", "RId", "RIe", are defin...
|
|
WO/2015/179956A1 |
The present disclosure relates to compounds having the Formula (Formula (I)) which are inhibitors of STAT5.
|
|
WO/2015/165279A1 |
Provided are new polyfluoro-substituted pyrazolopyrimidine compounds or salts represented by formulae (I) to (IX), a preparation method therefor, and a method for using said compounds and a preparation thereof to treat and inhibit autoim...
|
|
WO/2015/143866A1 |
Provided is a preparation method for bis-fluorosulfonyl imide and alkali metal salts thereof. The preparation method for bis-fluorosulfonyl imide comprises the steps of preparing the bis-fluorosulfonyl imide by reacting bis-chlorosulfony...
|
|
WO/2015/145371A1 |
The present invention relates to a compound of formula I, or an isotopic form, stereoisomer, a tautomer, a pharmaceutically acceptable salt, a solvate, a polymorph, a prodrug, N-oxide or S-oxide thereof; and processes for their preparati...
|
|
WO/2015/143185A1 |
Provided herein is the design and synthesis of novel molecular rotor fluorophores useful for detection of amyloid or amyloid like proteins. The fluorophores are designed to exhibit enhanced fluorescence emission upon associating with amy...
|
|
WO/2015/138496A1 |
Tricyclic chemical modulators of protein phosphatase 2A are disclosed. The compounds are useful to treat cancer, age-onset proteotoxicity, stress-induced depression, inflammation, and acne. The compounds are of the following phenothiazin...
|
|
WO/2015/138500A1 |
A genus of arylsulfonamide derivatives of aminocycloalkanols is disclosed. The compounds are of the following genus (I):. The compounds induce FOXO1 transcription factor translocation to the nucleus by modulating PP2A and, as a consequen...
|
|
WO/2015/129832A1 |
The present invention is a radiosensitive resin composition containing: a polymer having a structural unit that contains the group represented by formula (1); and a radiosensitive acid generator. In formula (1), R1 is a substituted or un...
|
|
WO/2015/127450A1 |
The present invention provides compounds and pharmaceutical compositions for treating neurological diseases such as multiple sclerosis.
|
|
WO/2015/110262A1 |
The present invention relates to compounds according to general formula (I) which are analogues of epoxymetabolites produced by cytochrome P450 (CYP) enzymes from omega-3 (n-3) polyunsaturated fatty acids (PUFAs). The present invention f...
|
|
WO/2015/108136A1 |
The present invention provides: a novel α-substituted glycinamide derivative or a pharmacologically acceptable salt thereof; a pharmaceutical composition containing the compound or the pharmacologically acceptable salt; and a use of the...
|
|
WO/2015/109210A1 |
The disclosed subject matter provides N-hydroxymethanesulfonamide compounds, pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, the disclosed...
|
|
WO/2015/087857A1 |
Provided is an aryl amidine compound that has excellent bactericidal activity, is highly safe, can be synthesized in an industrially advantageous manner, and is represented by formula (II) or the like. Also provided is a bactericidal age...
|
|
WO/2015/088000A1 |
The objective of the present invention is to provide a novel low molecular weight compound which exhibits an orexin agonist activity and is expected to be useful as an excellent therapeutic or preventive agent for narcolepsy. The present...
|
|
WO/2015/082533A1 |
The present invention relates to compounds according to Formula I: Wherein: A11 - A14 are N or CR11, CR12, CR13, CR14, respectively, with the proviso that no more than two of the four positions A can be simultaneously N; R1 is C(1-6)alky...
|
|
WO/2015/082938A1 |
The present invention relates to a compound of formula I, or a pharmaceutically acceptable salt thereof : (I) wherein: n is 0 or 1; R1 is selected from H, alkyl and aralkyl, wherein said alkyl and aralkyl groups may be optionally substit...
|
